337 related articles for article (PubMed ID: 16476028)
21. Statins and tissue mineralization: putative involvement of alkaline phosphatase.
Negrão MR; Mota A; Azevedo I; Martins MJ
Med Hypotheses; 2006; 67(3):524-8. PubMed ID: 16644140
[TBL] [Abstract][Full Text] [Related]
22. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
23. The role of statins as potential targets for bone formation.
Garrett IR; Mundy GR
Arthritis Res; 2002; 4(4):237-40. PubMed ID: 12106493
[TBL] [Abstract][Full Text] [Related]
24. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
25. Statins and osteoporosis: can these lipid-lowering drugs also bolster bones?
Cruz AC; Gruber BL
Cleve Clin J Med; 2002 Apr; 69(4):277-8, 280-2, 287-8. PubMed ID: 11996199
[TBL] [Abstract][Full Text] [Related]
26. Pleiotropic effects and cholesterol-lowering therapy.
Shaw SM; Fildes JE; Yonan N; Williams SG
Cardiology; 2009; 112(1):4-12. PubMed ID: 18577880
[TBL] [Abstract][Full Text] [Related]
27. The effect of statins in heart failure: beyond its cholesterol-lowering effect.
Kurian KC; Rai P; Sankaran S; Jacob B; Chiong J; Miller AB
J Card Fail; 2006 Aug; 12(6):473-8. PubMed ID: 16911915
[TBL] [Abstract][Full Text] [Related]
28. [Statins as possible therapeutic tools for osteoporosis].
Takeuchi Y; Takeda S
Clin Calcium; 2004 Feb; 14(2):302-7. PubMed ID: 15576989
[TBL] [Abstract][Full Text] [Related]
29. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
[TBL] [Abstract][Full Text] [Related]
30. HMG CoA reductase inhibitors and the skeleton: a comprehensive review.
Bauer DC
Osteoporos Int; 2003 Jun; 14(4):273-82. PubMed ID: 12736772
[TBL] [Abstract][Full Text] [Related]
31. Influence of statins on MHC class I expression.
Singh P; Kohr D; Kaps M; Blaes F
Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
33. Potential antitumor effects of statins (Review).
Jakobisiak M; Golab J
Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986
[TBL] [Abstract][Full Text] [Related]
34. [Statins and their pleiotropic effects].
Galus R; Zandecki Ł; Jóźwiak J; Włodarski K
Pol Merkur Lekarski; 2008 Jun; 24(144):545-8. PubMed ID: 18702340
[TBL] [Abstract][Full Text] [Related]
35. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
Ray KK; Cannon CP; Ganz P
Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
[TBL] [Abstract][Full Text] [Related]
36. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
Gotto AM; Farmer JA
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
[TBL] [Abstract][Full Text] [Related]
37. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
38. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
39. Recent development in pleiotropic effects of statins on cardiovascular disease through regulation of transforming growth factor-beta superfamily.
Ma S; Ma CC
Cytokine Growth Factor Rev; 2011 Jun; 22(3):167-75. PubMed ID: 21700485
[TBL] [Abstract][Full Text] [Related]
40. Androgens, cardiovascular disease and osteoporosis.
Isidori AM; Giannetta E; Pozza C; Bonifacio V; Isidori A
J Endocrinol Invest; 2005; 28(10 Suppl):73-9. PubMed ID: 16550728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
